Cargando…

Somatic TP53 variants frequently confound germline testing results

PURPOSE: Blood/saliva DNA is thought to represent the germline in genetic cancer risk assessment. Cases with pathogenic TP53 variants detected by multi-gene panel tests (MGPT) are often discordant with Li-Fraumeni Syndrome (LFS), raising concern about misinterpretation of acquired aberrant clonal ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weitzel, Jeffrey N., Chao, Elizabeth C., Nehoray, Bita, Van Tongeren, Lily R., LaDuca, Holly, Blazer, Kathleen R., Slavin, Thomas, Pesaran, Tina, Rybak, Christina, Solomon, Ilana, Niell-Swiller, Mariana, Dolinsky, Jill S., Castillo, Danielle, Elliott, Aaron, Gau, Chia-Ling, Speare, Virginia, Jasperson, Kory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976505/ https://www.ncbi.nlm.nih.gov/pubmed/29189820 http://dx.doi.org/10.1038/gim.2017.196

Ejemplares similares

Corrigendum: Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management
por: Slavin, Thomas Paul, et al.
Publicado: (2015)

Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management
por: Slavin, Thomas Paul, et al.
Publicado: (2015)

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations
por: Horton, Carolyn, et al.
Publicado: (2022)

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients
por: LaDuca, Holly, et al.
Publicado: (2014)

Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield
por: Horton, Carolyn, et al.
Publicado: (2022)

Universal Multi Gene Panel Testing For Individuals With Pheochromocytomas And Paragangliomas
por: Horton, Carolyn, et al.
Publicado: (2021)

The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort
por: Hu, Chunling, et al.
Publicado: (2020)

Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes
por: Pesaran, T., et al.
Publicado: (2016)

Negative Frequency-Dependent Selection Is Frequently Confounding
por: Brisson, Dustin
Publicado: (2018)

Comprehensive Paired Tumor/Germline Testing for Lynch Syndrome: Bringing Resolution to the Diagnostic Process
por: Salvador, Monalyn U., et al.
Publicado: (2019)

Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients
por: Kwong, Ava, et al.
Publicado: (2020)

Genetic basis of Cowden syndrome and its implications for clinical practice and risk management
por: Gammon, Amanda, et al.
Publicado: (2016)

Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort
por: Li, Hongyan, et al.
Publicado: (2019)

Classification of the canonical splice alteration MUTYH c.934-2A > G is likely benign based on RNA and clinical data
por: Hernandez, Felicia, et al.
Publicado: (2022)

Effect of smoking on urothelial cancer risk in individuals with Lynch syndrome
por: Kohlmann, Wendy, et al.
Publicado: (2010)

Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
por: Hu, Chunling, et al.
Publicado: (2018)

Development and Pilot Implementation of the Genomic Risk Assessment for Cancer Implementation and Sustainment (GRACIAS) Intervention in Mexico
por: Blazer, Kathleen R., et al.
Publicado: (2021)

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients
por: LaDuca, Holly, et al.
Publicado: (2019)

Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic center
por: Elliott, Elizabeth, et al.
Publicado: (2020)

Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma
por: Burack, W. Richard, et al.
Publicado: (2023)

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

Frequent and Simultaneous Epigenetic Inactivation of TP53 Pathway Genes in Acute Lymphoblastic Leukemia
por: Vilas–Zornoza, Amaia, et al.
Publicado: (2011)

Rlip depletion prevents spontaneous neoplasia in TP53 null mice
por: Awasthi, Sanjay, et al.
Publicado: (2018)

Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis
por: Kratz, Christian P., et al.
Publicado: (2021)

catena-Poly[[[aquacopper(II)]-μ-(biphenyl-2,2′-dicarboxylato)-μ-[N,N′-bis(pyridin-4-yl)urea]] 1.25-hydrate]
por: Uzorka, Ben, et al.
Publicado: (2020)

Poly[[μ-1,3-bis(pyridin-3-yl)urea]bis(μ(4)-succinato)dicopper(II)], a ribbon-like coordination polymer
por: Ezenyilimba, Frederick, et al.
Publicado: (2023)

Poly[[aqua[μ(2)-1,3-bis(pyridin-4-yl)urea-κ(2) N (4):N (4′)]bis(μ(3)-5-tert-butylisophthalato-κ(3) O (1):O (1′):O (3))dizinc(II)] trihydrate], a double-strand coordination polymer
por: Jia, Jason, et al.
Publicado: (2023)

Poly[[μ-1,4-bis(pyridin-4-ylmethyl)piperazine]bis[μ(3)-4-(2-carboxylatoethyl)benzoato]dicopper(II)]
por: Jia, Jason, et al.
Publicado: (2023)

Poly[bis[μ(2)-1,3-bis(pyridin-4-yl)urea-κ(2) N (4):N (4′)]bis(μ(2)-5-methylisophthalato-κ(2) O (1):O (3))dizinc(II)], a parallel interpenetrated slab-like coordination polymer with {3.6(4)8}{3(2)6.7(2)8} 4,4-connected binodal topology
por: Jia, Jason, et al.
Publicado: (2023)

Confounding
por: Andrade, Chittaranjan
Publicado: (2007)

Low density DNA microarray for detection of most frequent TP53 missense point mutations
por: Rangel-López, Angélica, et al.
Publicado: (2005)

Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12
por: Mäkinen, Netta, et al.
Publicado: (2016)

TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclear
por: Monti, Paola, et al.
Publicado: (2017)

TP53-dependent toxicity of CRISPR/Cas9 cuts is differential across genomic loci and can confound genetic screening
por: Álvarez, Miguel M., et al.
Publicado: (2022)

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
por: Pritzlaff, Mary, et al.
Publicado: (2016)

Diagnosing hereditary cancer predisposition in men with prostate cancer
por: Pritzlaff, Mary, et al.
Publicado: (2020)

The effects of genomic germline variant reclassification on clinical cancer care
por: Slavin, Thomas P., et al.
Publicado: (2019)

Bis(dimethylmalonato-κ(2) O,O′)bis[4-(4-pyridylamino-κN (4))pyridinium]nickel(II) hexahydrate
por: Farnum, Gregory A., et al.
Publicado: (2008)

Poly[di-μ(3)-chlorido-[μ(2)-(3-pyridyl)(4-pyridyl)methanone-κ(2) N:N′]dicopper(I)]
por: Hittle, Jennifer L., et al.
Publicado: (2008)

Poly[4,4′-iminodipyridinium [di-μ(4)-isophthalato-κ(4) O:O′:O′′:O′′-di-μ(3)-isophthalato-κ(3) O:O′:O′′;κ(4) O:O′:O′′,O′′′-trizinc(II)] dihydrate]
por: Braverman, Maxwell A., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_e7ae2vdn4um4g2lco5vo3h2ilu